Literature Highlights - March 2023
This highlight deck is comprised of 6 papers
Each month the Lupus Forum Steering Committee selects the latest published original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.
Literature Highlights - February 2023
This highlight deck is comprised of 5 papers
Keywords:
Neuropsychiatric disease, Economic burden, EULAR, ACR, Organ damage, LLDAS, Anifrolumab, Fatigue, QoL, PROs, Transcriptomic signature
Literature Highlights - January 2023
This highlight deck is comprised of 5 papers
Keywords:
Evobrutinib, Biologics, Systematic review, DMARDs, Belimumab, Pregnancy, Dapirolizumab, Real-world, Childhood-onset SLE
Literature Highlights - December 2022
This highlight deck is comprised of 4 papers
Keywords:
Biologics, B-lymphocytes, Biomarkers, Deucravacitinib, TYK2, Phase II, Anifrolumab, Phase III, Long-term, Safety, Interleukin-2, Treg
Literature Highlights - November 2022
This highlight deck is comprised of 3 papers
Keywords:
Belimumab, Lupus nephritis, Safety, LLDAS, Remission, Real-world
Literature Highlights - October 2022
This highlight deck is comprised of 7 papers
Keywords:
Litifilimab, Belimumab, Pregnancy, CAR T Therapy, Anifrolumab, Meta-analysis, Pathogenesis
Literature Highlights - September 2022
This highlight deck is comprised of 2 papers
Keywords:
Biologics, QoL, Cardiovascular risk
Literature Highlights - August 2022
This highlight deck is comprised of 8 papers
Keywords:
Anifrolumab, Cutaneous lupus erythematosus, Lupus nephritis, EULAR, ACR, Damage accrual, Ethnicity, Disease flare, Belimumab, Tacrolimus, Remission, SLICC, Litifilimab
Literature Highlights - July 2022
This highlight deck is comprised of 6 papers
Keywords:
Immunosuppressants, Baricitinib, Biomarkers, Ustekinumab, Adverse events, Rituximab, Obinutuzumab, B-cell depletion, Hydroxychloroquine
Literature Highlights - June 2022
This highlight deck is comprised of 4 papers